AHFS Drug Information 2016

Beschreibung

With extensive updated information on everything from treatment of hypertension to HIV, AHFS Drug Information® 2016 is a necessary addition to your pharmacy’s resources. With content supported by more than 86,000 total references and reviewed by over 500 professionals, AHFS DI® helps you protect your patients and your business. The only print compendium designated by the U.S. Congress, AHFS DI 2016 is also the only reference published by a professional and scientific society - ensuring it is the most authoritative and best-selling reference trusted by pharmacists for 58 years. AHFS DI contains the most trustworthy drug information available - all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses. Updates for this edition include: Expanded and revised content throughout, featuring critical new  monograph updates every year Important updated monographs and references related to revised therapeutic guidelines, including recommendations for the treatment of hypertension, elevated cholesterol, and HIV infections Newly published information on breakthrough oncology drugs recently approved as part of the FDA’s accelerated approval program Dedicated coverage to orphan products Interactions, adverse reactions, cautions, and more Therapeutic recommendations supported by evidence from primary research Preparations, chemistry, and stability Pharmacology and pharmacokinetics Prescription, OTC, ophthalmic and dermatologic drugs Extensive off-label uses and dosing options Vaccines and other immunizing agents

Autor*in

ASHP American Society of Health-System Pharmacists

Themen in »AHFS Drug Information 2016«

2016 AHFS DI 2016 AHFS Drug Information 2016 Internationale Fachliteratur Pharmazie

Stimmen zu »AHFS Drug Information 2016«

Details

Link teilen